APA (7th ed.) Citation

Petrova, D., Weberbauer, M., Reichert, S., Scheid, S., Esser, J., Fink, K., . . . Helbing, T. Semaphorin 3F is elevated in serum of heart failure patients and inhibits cardiac angiogenesis via the VEGF/Akt/eNOS pathway. Elsevier.

Chicago Style (17th ed.) Citation

Petrova, Diana, Miki Weberbauer, Stephanie Reichert, Stephanie Scheid, Jennifer Esser, Katrin Fink, Daniel Duerschmied, Martin Moser, and Thomas Helbing. Semaphorin 3F Is Elevated in Serum of Heart Failure Patients and Inhibits Cardiac Angiogenesis via the VEGF/Akt/eNOS Pathway. Elsevier.

MLA (9th ed.) Citation

Petrova, Diana, et al. Semaphorin 3F Is Elevated in Serum of Heart Failure Patients and Inhibits Cardiac Angiogenesis via the VEGF/Akt/eNOS Pathway. Elsevier.